C
Cue Biopharma, Inc. (CUE)
NCM – Real Time Price. Currency in USD
25.39
-0.15 (-0.59%)
At close: Jun 26, 2026, 4:00 PM EDT
25.09
-0.30 (-1.18%)
After-hours: Jun 26, 2026, 5:11 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
25.39
-0.15 (-0.59%)
At close: Jun 26, 2026, 4:00 PM EDT
25.09
-0.30 (-1.18%)
After-hours: Jun 26, 2026, 5:11 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $16.4M significantly exceed its total debt $3.4M, ensuring strong financial flexibility
Total current assets $26.4M exceed Total current liabilities $7.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1,340.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$11.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.57 | 6.05 | 10 | |
| Quick ratio | 3.57 | 5.63 | 10 | |
| Debt to Equity | 0.16 | 0.30 | 9.0 | |
| Debt to Assets | 0.11 | 1.04 | 8.0 | |
| Interest coverage | -1340.75 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1M | 5M | 9M | 27M | 33M |
| Gross Profit | -561K | 2M | 7M | 27M | 32M |
| Operating Income | -54M | -52M | -42M | -27M | -20M |
| Net Income | -53M | -51M | -41M | -27M | -20M |
| EBITDA | -52M | -49M | -39M | -26M | -19M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1.56 | 37.41 | 6.5 |
| Next quarter | -2.28 | 9.05 | 3.5 |
| Current year | -53.4 | 20.95 | 5.5 |
| Next year | -92.19 | -42.32 | 1.0 |
| Weighted average score | 4.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -74.08 | -426.68 | -459.99 | -928.15 | 1.0 |
| Y/Y | 1250.59 | 57.75 | 78.82 | -32.93 | 7.8 |
| 3y average | 201.93 | 19.58 | 40.58 | 17.88 | 9.5 |
| 5y average | 177.56 | 8.02 | 25.14 | 5.59 | 7.8 |
| Weighted average score | 6.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |